BR0108433A - sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições - Google Patents

sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições

Info

Publication number: BR0108433A
Authority: BR; Brazil
Prior art keywords: flavoring; pharmaceutical compositions; mixtures; making; compositions
Prior art date: 2000-09-05

Application number

BRPI0108433-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Laman Alani

Donald P Gauwitz

Dilip Kaul

John M Lipari

Soumojeet Ghosh

Kennan C Marsh

Richard H Whelan

Vanik D Petrossian

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2001-09-04

Publication date

2006-06-06

2001-09-04 Application filed by Abbott Lab filed Critical Abbott Lab

2006-06-06 Publication of BR0108433A publication Critical patent/BR0108433A/pt

Links

239000000203 mixture Substances 0.000 title abstract 6
239000008194 pharmaceutical composition Substances 0.000 title abstract 6
239000004615 ingredient Substances 0.000 abstract 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
235000003599 food sweetener Nutrition 0.000 abstract 2
239000007788 liquid Substances 0.000 abstract 2
239000003765 sweetening agent Substances 0.000 abstract 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
229920000742 Cotton Polymers 0.000 abstract 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
KJHKTHWMRKYKJE-SUGCFTRWSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O KJHKTHWMRKYKJE-SUGCFTRWSA-N 0.000 abstract 1
244000246386 Mentha pulegium Species 0.000 abstract 1
235000016257 Mentha pulegium Nutrition 0.000 abstract 1
235000004357 Mentha x piperita Nutrition 0.000 abstract 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 abstract 1
244000290333 Vanilla fragrans Species 0.000 abstract 1
235000009499 Vanilla fragrans Nutrition 0.000 abstract 1
235000012036 Vanilla tahitensis Nutrition 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
235000009508 confectionery Nutrition 0.000 abstract 1
239000000796 flavoring agent Substances 0.000 abstract 1
235000019634 flavors Nutrition 0.000 abstract 1
235000011187 glycerol Nutrition 0.000 abstract 1
235000019534 high fructose corn syrup Nutrition 0.000 abstract 1
235000001050 hortel pimenta Nutrition 0.000 abstract 1
229960004525 lopinavir Drugs 0.000 abstract 1
229940041616 menthol Drugs 0.000 abstract 1
239000003607 modifier Substances 0.000 abstract 1
229910052700 potassium Inorganic materials 0.000 abstract 1
239000011591 potassium Substances 0.000 abstract 1
NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 abstract 1
229960000311 ritonavir Drugs 0.000 abstract 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 abstract 1
239000011780 sodium chloride Substances 0.000 abstract 1
239000001509 sodium citrate Substances 0.000 abstract 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fats And Perfumes (AREA)

BRPI0108433-0A 2000-09-05 2001-09-04 sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições BR0108433A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US65519200A	2000-09-05	2000-09-05
PCT/US2001/027415 WO2002020057A2 (fr)	2000-09-05	2001-09-04	Systeme d'aromatisation pour compositions pharmaceutiques et procedes de fabrication de telles compositions

Publications (1)

Publication Number	Publication Date
BR0108433A true BR0108433A (pt)	2006-06-06

Family

ID=24627898

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0108433-0A BR0108433A (pt)	2000-09-05	2001-09-04	sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições

Country Status (10)

Country	Link
EP (1)	EP1315487A2 (fr)
JP (1)	JP2004522698A (fr)
AR (1)	AR030715A1 (fr)
AU (1)	AU2001288695A1 (fr)
BR (1)	BR0108433A (fr)
CA (1)	CA2417258A1 (fr)
MX (1)	MXPA03001952A (fr)
PE (1)	PE20020373A1 (fr)
UY (1)	UY26925A1 (fr)
WO (1)	WO2002020057A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
EP1175205B1 (fr)	1999-11-12	2006-06-14	Abbott Laboratories	Dispersion solide comrpenant ritonavir, fenofibrate ou griseofulvin
RU2005119299A (ru) *	2002-11-22	2005-11-20	Фирмениш Са (Ch)	Составы для ухода за полостью рта, маскирующие соленый вкус солей
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
GB2423711B (en) *	2005-10-24	2007-02-14	Fortune Apex Dev Ltd	Method for preparing a pharmaceutical composition with enhanced mucoadhesion
TW201340998A (zh) *	2012-02-29	2013-10-16	Takeda Pharmaceutical	經口劑
US8771651B2 (en) *	2012-09-10	2014-07-08	Johnson & Johnson Consumer Companies, Inc.	Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL111991A (en) *	1994-01-28	2000-07-26	Abbott Lab	Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) *	1996-06-03	1998-01-05	Merck & Co., Inc.	Pediatric formulation for hiv protease inhibitors

2001
- 2001-09-04 MX MXPA03001952A patent/MXPA03001952A/es unknown
- 2001-09-04 AU AU2001288695A patent/AU2001288695A1/en not_active Abandoned
- 2001-09-04 AR ARP010104207A patent/AR030715A1/es unknown
- 2001-09-04 JP JP2002524540A patent/JP2004522698A/ja not_active Withdrawn
- 2001-09-04 UY UY26925A patent/UY26925A1/es not_active Application Discontinuation
- 2001-09-04 WO PCT/US2001/027415 patent/WO2002020057A2/fr not_active Ceased
- 2001-09-04 EP EP01968449A patent/EP1315487A2/fr not_active Withdrawn
- 2001-09-04 CA CA002417258A patent/CA2417258A1/fr not_active Abandoned
- 2001-09-04 PE PE2001000889A patent/PE20020373A1/es not_active Application Discontinuation
- 2001-09-04 BR BRPI0108433-0A patent/BR0108433A/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
MXPA03001952A (es)	2003-09-10
EP1315487A2 (fr)	2003-06-04
JP2004522698A (ja)	2004-07-29
UY26925A1 (es)	2002-04-26
AR030715A1 (es)	2003-09-03
AU2001288695A1 (en)	2002-03-22
PE20020373A1 (es)	2002-05-13
WO2002020057A2 (fr)	2002-03-14
CA2417258A1 (fr)	2002-03-14
WO2002020057A3 (fr)	2002-05-10

Legal Events

Date	Code	Title	Description
2008-08-19	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.
2009-04-07	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.

Publication	Publication Date	Title
ES2402544T3 (es)	2013-05-06	Preparación pelicular rápidamente soluble
BR0211794A (pt)	2004-11-03	Composição farmacêutica e método para mascarar o sabor de pelo menos um composto farmaceuticamente ativo de sabor desagradável
AU2017203009B2 (en)	2018-07-19	Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
US5902606A (en)	1999-05-11	Solid and liquid solutions of sparingly water-soluble medicinal substances
UA79196C2 (en)	2007-05-25	Intranasal formulation of rotigotine
KR950703327A (ko)	1995-09-20	씹을 수 있는 라니티딘 정제(Ranitidine Chewable Tablets)
ES2947572T3 (es)	2023-08-11	Composiciones de diferentes densidades para comprimidos multicapa de desintegración rápida
BR0108433A (pt)	2006-06-06	sistemas flavorizantes para composições farmacêuticas e métodos para fazer tais composições
GB2228412A (en)	1990-08-29	Nicardipine pharmaceutical composition for parenteral administration
PE20030545A1 (es)	2003-06-19	Formulaciones de jarabe de ribavirina
JP2003128583A (ja)	2003-05-08	清涼化組成物
JP2002348236A (ja)	2002-12-04	医薬液剤
ES2392967T3 (es)	2012-12-17	Formulaciones mejoradas que contienen derivados de imidazol sustituido
US7429390B2 (en)	2008-09-30	Stable pharmaceutical compositions, processes for making the same and methods of their use
BR0302523A (pt)	2005-04-05	Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease
KR102556874B1 (ko)	2023-07-18	비스포스포네이트 및 콜레칼시페롤을 함유하는 경구용 에멀젼 조성물 및 그 제조방법
TH51212A (th)	2002-05-28	ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว
JP2000515556A (ja)	2000-11-21	ニメスライド含有経口投与用薬剤
KR20030047503A (ko)	2003-06-18	소브레롤·아세트아미노펜 복합 건조시럽제 및 액제
JP2001213764A (ja)	2001-08-07	内服液剤
JP2007008852A (ja)	2007-01-18	プラバスタチンを含有する水性製剤の安定化方法
JPS63313734A (ja)	1988-12-21	シロツプ剤
JPS647967B2 (fr)	1989-02-10
RU95101240A (ru)	1997-02-27	Способ получения средства, обеспечивающего снижение токсичности парацетамола
TH73889B (th)	2020-01-22	ยาเม็ดแกรนูลเมโลซิแคมที่ละลายน้ำได้